Literature DB >> 9817743

Structural and functional changes in the airway smooth muscle of asthmatic subjects.

C Y Seow1, R R Schellenberg, P D Paré.   

Abstract

It has been recognized since the early 1920s that the amount of smooth muscle in asthmatic subjects' airways is markedly increased. More recent studies have confirmed that in fatal asthma there is a significant increase in the thickness of airway smooth muscle. For subjects who have had asthma and who died for other reasons or had a lobectomy, the increase in muscle layer thickness is less striking. An increase in smooth muscle mass could have a dual effect on airway narrowing: one due to the thickening of airway wall, the other due to a concomitant increase in force generation. However, it is not known whether the increased muscle mass, due either to hypertrophy or hyperplasia, is accompanied by an increase in force. Proliferation of smooth muscle cells often produces noncontractile cells in vitro. Comparison of force generation by muscle preparations from asthmatic and control airways shows conflicting results, with some studies demonstrating an increase in force in asthmatic muscle preparations and others showing no increase. The discrepancy could be due to a failure to take into account the length-tension relationship of the muscle preparations in some studies. No force velocity data are available for human airway smooth muscle. However, there is some evidence for an increased amount of shortening in airway smooth muscle preparations from patients with asthma. This could be due to an increase in force generation and/or a decrease in tissue elastance in asthmatic airways. Muscle contractility and tissue elastance are in turn influenced by cytokines, matrix-degrading enzymes, and other inflammatory mediators present in the airways of asthmatic subjects. Data from in vitro studies of a canine "asthma model" indicate an increase in both shortening velocity and amount of shortening compared with littermate control animals. An increase in the compliance of the parallel elastic element of the sensitized airway preparation could account for the mechanical alterations.

Entities:  

Mesh:

Year:  1998        PMID: 9817743     DOI: 10.1164/ajrccm.158.supplement_2.13tac160

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  33 in total

1.  Regulator of G-protein signaling-5 inhibits bronchial smooth muscle contraction in severe asthma.

Authors:  Zhao Yang; Nariman Balenga; Philip R Cooper; Gautam Damera; Richard Edwards; Christopher E Brightling; Reynold A Panettieri; Kirk M Druey
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-26       Impact factor: 6.914

2.  Airway smooth muscle relaxation is impaired in mice lacking the p47phox subunit of NAD(P)H oxidase.

Authors:  Pasquale Chitano; Lu Wang; Stanley N Mason; Richard L Auten; Erin N Potts; William M Foster; Anne Sturrock; Thomas P Kennedy; John R Hoidal; Thomas M Murphy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-09       Impact factor: 5.464

Review 3.  Allergic Respiratory Inflammation and Remodeling.

Authors:  Kawa A M Amin
Journal:  Turk Thorac J       Date:  2015-07-01

Review 4.  Putting the Squeeze on Airway Epithelia.

Authors:  Jin-Ah Park; Jeffrey J Fredberg; Jeffrey M Drazen
Journal:  Physiology (Bethesda)       Date:  2015-07

5.  Differences in surfactant lipids collected from pleural and pulmonary lining fluids.

Authors:  Paul C Mills; Yi Chen; Yvette C Hills; Brian A Hills
Journal:  Pharm Res       Date:  2005-08-19       Impact factor: 4.200

6.  Myosin filament polymerization and depolymerization in a model of partial length adaptation in airway smooth muscle.

Authors:  Gijs Ijpma; Ahmed M Al-Jumaily; Simeon P Cairns; Gary C Sieck
Journal:  J Appl Physiol (1985)       Date:  2011-06-09

7.  The phosphatase CD148 promotes airway hyperresponsiveness through SRC family kinases.

Authors:  Tamiko R Katsumoto; Makoto Kudo; Chun Chen; Aparna Sundaram; Elliott C Callahan; Jing W Zhu; Joseph Lin; Connor E Rosen; Boryana N Manz; Jae W Lee; Michael A Matthay; Xiaozhu Huang; Dean Sheppard; Arthur Weiss
Journal:  J Clin Invest       Date:  2013-04-01       Impact factor: 14.808

8.  Phenotype, endotype and patient-specific computational modelling for optimal treatment design in asthma.

Authors:  Graham M Donovan; Merryn H Tawhai
Journal:  Drug Discov Today Dis Models       Date:  2014-04-29

Review 9.  Airway remodeling: lessons from animal models.

Authors:  David Ramos-Barbón; Mara S Ludwig; James G Martin
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

Review 10.  Differences in airway remodeling between asthma and chronic obstructive pulmonary disease.

Authors:  Kazutetsu Aoshiba; Atsushi Nagai
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.